Font size
S
M
L
XL
WorksheetsMD MPJE Pharmacist Practice
Total questions: 80
Worksheet time: 27mins
Name
Class
Date
1.
Before a pharmacist in Maryland may administer vaccinations, they must submit a registration form that verifies:
a)
Completion of an online self‑study module only
b)
Holding any health‑related degree
c)
Employment at a hospital pharmacy
d)
Completion of a Board‑approved certification course and active CPR certification
e)
Not stated in regulations
2.
A pharmacist’s registration to administer vaccinations expires:
a)
After one year regardless of CE
b)
When the pharmacist’s license to practice pharmacy expires unless the pharmacist completes required vaccination CE and license renewal
c)
Not stated in regulations
d)
Never, once obtained it is permanent
e)
Only when the Board revokes it
3.
Which of the following is NOT required before a pharmacist administers a vaccine?
a)
Maintaining active CPR certification
b)
Submitting a change of address to the Board
c)
Completing a Board‑approved certification course
d)
Receiving written confirmation from the Board accepting the pharmacist’s registration
e)
Not stated in regulations
4.
Under Maryland regulations, a pharmacist may administer an influenza vaccination without a prescription to an individual who is:
a)
Any age as long as the parent consents
b)
Not stated in regulations
c)
Only adults 18 years and older
d)
9 years of age or older, following an approved protocol
e)
5 years of age or older
5.
For vaccines on the CDC schedule given to individuals between 11 and 18 years old, a pharmacist may administer the vaccine only if:
a)
The individual signs a waiver
b)
The parent verbally authorizes it at the pharmacy
c)
The individual has a prescription from an authorized prescriber
d)
It is an influenza vaccine
e)
Not stated in regulations
6.
Which elements must be included in a Board‑approved vaccination training program?
a)
Responding to vaccination emergencies
b)
Administering intramuscular and subcutaneous injections
c)
Record‑keeping and reporting
d)
Guidelines from ACIP and CDC
e)
Selecting vaccine manufacturers
7.
What are pharmacist obligations regarding patient information and consent when administering vaccinations?
a)
Provide the patient with the current vaccine information statement
b)
Obtain a signed consent form
c)
Observe the patient for at least 15 minutes after vaccination
d)
Disclose the pharmacist’s credentials on the consent form
e)
Require the patient to sign a liability waiver
8.
Which items must be documented and kept by the pharmacy for at least 5 years after administering a vaccination?
a)
Patient’s name, address, and date of birth
b)
Route and site of administration
c)
Vaccine lot number and expiration date
d)
Name of the primary health care provider
e)
Patient’s insurance group number
9.
After a vaccination, what must be documented regarding any adverse reaction?
a)
Only the patient’s report of discomfort
b)
Insurance billing codes
c)
A brief note that the vaccine was given
d)
The nature and outcome of the reaction and notification to the primary provider and VAERS
e)
Not stated in regulations
10.
Which statement about retaining vaccination records is FALSE?
a)
Records for minors must be kept until the patient reaches majority plus 3 years or 5 years after the record is made, whichever is later
b)
Not stated in regulations
c)
Records must be kept at least 5 years
d)
Records must be readily retrievable and available to the Board
e)
Records for minors may be destroyed 3 years after vaccination regardless of age
11.
A pharmacist must have a written protocol for each vaccine administered. What elements must this protocol include?
a)
Identity and license number of the participating pharmacist
b)
The specific vaccine
c)
Precautions and contraindications
d)
Process for screening indications, precautions, and contraindications
e)
Patient’s insurance eligibility
12.
After administering a vaccine, what actions must a pharmacist take?
a)
Provide the patient with a vaccine information statement
b)
Observe the patient for at least 15 minutes
c)
Obtain a signed consent form
d)
All of the above
e)
Document the transaction in the pharmacy's financial ledger
13.
Which of the following administrative tasks may a pharmacist delegate to an untrained cashier when giving vaccinations?
a)
Obtain patient consent
b)
Determine vaccine eligibility
c)
Provide post‑vaccination observation
d)
None of the above
e)
Record the vaccination in the state immunization registry
14.
Which items must a protocol for drug therapy management include?
a)
The condition the protocol is designed to manage
b)
A list of medications allowed
c)
Monitoring parameters including laboratory tests
d)
Circumstances requiring contact with the prescriber
e)
Names of all patients enrolled
15.
Under a drug therapy management protocol, pharmacists may be authorized to:
a)
Prescribe controlled substances independently
b)
Diagnose new conditions without prescriber input
c)
Modify, continue, or discontinue drug therapy and order laboratory tests
d)
Not stated in regulations
e)
Perform surgical procedures
16.
A drug therapy management protocol may NOT authorize pharmacists to:
a)
Initiate therapy under a written protocol
b)
Not stated in regulations
c)
Order laboratory tests
d)
Perform acts that exceed the scope of practice of the parties to the agreement
e)
Modify a dosage under the terms of the contract
17.
What must be included in a prescriber‑pharmacist agreement for drug therapy management?
a)
Names and signatures of authorized prescribers and pharmacists
b)
Locations where services will be provided
c)
Titles of the applicable protocols
d)
Methods and time frames for documentation and communication
e)
Prescriber’s personal financial statements
18.
Technical modifications to a prescriber‑pharmacist agreement must be registered with the Board within:
a)
90 days of the modification
b)
30 days of the modification
c)
3 days of the modification
d)
Only at license renewal
e)
Not stated in regulations
19.
What qualifications must a pharmacist meet to enter into a therapy management contract?
a)
Be licensed and in good standing with the Board
b)
Possess a Doctor of Pharmacy degree or equivalent training
c)
Have no public disciplinary orders within the last 5 years
d)
Hold advanced credentials or complete Board‑approved residency or certificate training
e)
Serve as chair of the Board
20.
Under the guidelines for use of protocols, a pharmacist must inform the authorized prescriber within 48 hours if the pharmacist:
a)
Dispenses an over‑the‑counter medication
b)
Not stated in regulations
c)
Collects payment for services
d)
Modifies the dose or agent, detects an abnormal result, or initiates therapy under the protocol
e)
Schedules a follow‑up appointment
21.
Who must sign a therapy management contract?
a)
Not stated in regulations
b)
The authorized prescriber(s), the pharmacist(s), and the patient
c)
Only the pharmacist and patient
d)
The prescriber, pharmacist, and Board representative
e)
Only the prescriber and pharmacist
22.
Which statements are required in a therapy management contract?
a)
A list of allowable substitutions of chemically dissimilar drugs, if any
b)
A statement that participation is voluntary and not coerced
c)
Notice that the patient may terminate the contract at any time
d)
A procedure for periodic review of drugs modified
e)
Patient’s insurance premium details
23.
What fee does the Board of Pharmacy require for each prescriber‑pharmacist agreement and protocol application?
a)
Not stated in regulations
b)
$250 per agreement
c)
$100 per agreement
d)
No fee is required
e)
$50 per agreement
24.
Before prescribing and dispensing a nicotine replacement therapy medication, a pharmacist must:
a)
Hold a separate tobacco retailer license
b)
Not stated in regulations
c)
Be certified in immunization
d)
Complete a Board‑approved training program developed for nicotine replacement prescribing or have completed equivalent training in their formal education
e)
Serve on the Board of Pharmacy
25.
Which pharmacist is exempt from completing an additional nicotine replacement therapy training program?
a)
A pharmacist with 10 years of practice experience
b)
A pharmacist who received nicotine replacement prescribing training as part of their formal education
c)
A pharmacist who works in a hospital
d)
Not stated in regulations
e)
A pharmacist who completed immunization training
26.
When a pharmacist prescribes a nicotine replacement therapy medication, which follow‑up actions are required?
a)
Provide appropriate counseling on use
b)
Provide the patient with a visit summary
c)
Refer the patient to their primary care provider for additional care
d)
Record the prescribing and dispensing in the patient’s health record
e)
Collect a blood sample for nicotine levels
27.
Which of the following additional steps is required when prescribing nicotine replacement therapy?
a)
Monitoring the patient’s credit score
b)
Issuing a driver’s license waiver
c)
Performing a pulmonary function test
d)
None of the above
e)
Documenting the patient's occupation
28.
If a pharmacist has not completed an approved nicotine replacement therapy training program and did not receive such training in formal education, the pharmacist:
a)
May prescribe only lozenges
b)
Not stated in regulations
c)
May prescribe with physician oversight
d)
May dispense but not prescribe
e)
May not prescribe or dispense a nicotine replacement therapy medication
29.
Under Maryland regulations, which document must the Board develop before pharmacists can prescribe contraceptives?
a)
Not stated in regulations
b)
A self‑screening risk assessment questionnaire and a standard procedure algorithm for patient assessment
c)
A prescription pad with Board letterhead
d)
A list of participating pharmacies
e)
A national pharmacology textbook
30.
How far in advance must a pharmacist submit the Board’s notification form before prescribing contraceptives?
a)
At least 15 days before prescribing
b)
At least 30 days before prescribing
c)
No notification is required
d)
After prescribing the first contraceptive
e)
Not stated in regulations
31.
Which pharmacist is exempt from completing a Board‑approved training program before submitting the notification to prescribe contraceptives?
a)
Not stated in regulations
b)
One who practices in an institutional pharmacy
c)
One who has undergone contraceptive prescribing training as part of their formal education
d)
One who has completed an immunization training program
e)
One who holds a nurse practitioner license
32.
After submitting the notification form to the Board, a pharmacist may begin prescribing contraceptives:
a)
After completing a pharmacy‑sponsored webinar
b)
After waiting 30 days
c)
Only after receiving written confirmation from the Board accepting the notification
d)
Immediately upon mailing the form
e)
Not stated in regulations
33.
For a new patient requesting contraceptive services, a pharmacist must:
a)
Obtain the completed Board‑approved self‑screening risk assessment questionnaire
b)
Use the standard procedure algorithm to assess the patient
c)
Determine which contraceptive options to prescribe
d)
Refer the patient to a primary or reproductive health care provider after prescribing
e)
Have the patient complete an insurance claim form
34.
When a pharmacist prescribes contraceptives, what must be provided to the patient?
a)
A medical diploma
b)
A coupon for future purchases
c)
A visit summary explaining the contraceptive dispensed and encouraging follow‑up with a primary care provider
d)
Not stated in regulations
e)
A copy of the pharmacist’s license
35.
If a pharmacist decides not to prescribe contraceptives after completing all required assessments, they must:
a)
Refer the patient directly to the emergency department
b)
Provide the patient with a visit summary explaining the basis for the decision not to prescribe
c)
Destroy the patient’s questionnaire
d)
Charge a counseling fee
e)
Not stated in regulations
36.
A Board‑approved training program for pharmacists prescribing contraceptives must cover which topics?
a)
An overview of contraceptive medications and devices
b)
The self‑screening risk assessment questionnaire
c)
The standard procedure contraceptive algorithm
d)
U.S. Medical Eligibility Criteria for Contraceptive Use
e)
Billing practices for insurance
37.
Which details must a pharmacy maintain for at least 5 years when pharmacists prescribe contraceptives?
a)
Type and dosage of contraceptive prescribed or basis for not prescribing
b)
Patient’s name, address, and date of birth
c)
Name of the prescribing pharmacist
d)
Copy of the patient’s visit summary and self‑screening questionnaire
e)
The patient’s annual income
38.
How much Board‑approved continuing education related to contraception must a pharmacist earn before renewing a license after prescribing contraceptives?
a)
At least 1 hour
b)
At least 4 hours
c)
5 hours every five years
d)
Not stated in regulations
e)
No specific continuing education is required
39.
Under Maryland patient safety regulations, when must information about the patient’s role in preventing medication errors be provided?
a)
At the next annual checkup
b)
Not stated in regulations
c)
Only upon request
d)
After the first refill
e)
Before or at the time the drug or device is presented to the patient
40.
What information must be included when educating patients about preventing medication errors?
a)
A patient’s rights when receiving medications
b)
The patient’s role and responsibility in preventing errors
c)
Procedures for reporting suspected medication errors
d)
How to report an error to the Board
e)
Names of other patients with similar prescriptions
41.
In an inpatient setting, the medication error prevention information must be provided to:
a)
Not stated in regulations
b)
The patient and, if applicable, their health care agent or surrogate before discharge or made available in a conspicuous location
c)
No one, because inpatients are exempt
d)
Only the attending physician
e)
Insurance providers
42.
What is a pharmacist’s obligation regarding generically equivalent or therapeutically equivalent drugs?
a)
Automatically substitute a generic without informing the consumer
b)
Refuse to dispense generic equivalents
c)
Not stated in regulations
d)
Only inform consumers if asked
e)
Inform the consumer of the availability of a lower‑cost generically or therapeutically equivalent drug and the approximate cost difference
43.
In which situations is a pharmacist NOT required to inform a consumer about generic or therapeutically equivalent drug options?
a)
When the prescriber expressly states the prescription is to be dispensed only as directed
b)
When the pharmacy primarily serves institutional recipients
c)
When the cost is reimbursed by a third‑party payer
d)
When the drug is over‑the‑counter
e)
When a therapeutic equivalent is not available
44.
Under Maryland law, a pharmacist may substitute a generically equivalent or interchangeable biological product for the prescribed drug only if:
a)
The prescriber does not state that the prescription must be dispensed only as directed
b)
The substitution is recognized as therapeutically equivalent or interchangeable by the FDA
c)
The consumer is charged less for the substituted drug
d)
The substitution is documented on the prescription record
e)
The patient specifically demands the brand name
45.
When a pharmacist substitutes a drug under Maryland’s generic substitution law, what must they do?
a)
Notify the Board within 24 hours
b)
Notify the patient that the product dispensed is a generic or interchangeable equivalent and record the name and manufacturer of the substituted product
c)
Not stated in regulations
d)
Send a written letter to the prescriber for approval first
e)
Notify the insurance company only
46.
What procedure does the Board of Pharmacy maintain regarding failures to inform consumers about generic substitutes?
a)
Not stated in regulations
b)
An online auction of brand name drugs
c)
Automatic revocation of a pharmacist’s license
d)
A system to fine prescribers who forbid substitution
e)
A procedure for consumers to notify the Board when a pharmacist fails to provide required information and a process to advise the pharmacist to comply
47.
For a pharmacist to substitute a generic equivalent drug under Maryland law, which conditions must be met?
a)
Prescriber does not prohibit substitution
b)
The substitution is recognized as therapeutically equivalent or interchangeable
c)
The consumer is charged less
d)
All of the above
e)
The pharmacy has at least two pharmacists on duty
48.
Which of the following is a reason a pharmacist may automatically substitute a generic drug without following Maryland substitution rules?
a)
The patient requests the generic
b)
The drug is very expensive
c)
The pharmacist has excess generic stock
d)
None of the above
e)
The manufacturer offers a promotional discount
49.
Which of the following does NOT satisfy the advanced training requirement for pharmacists participating in drug therapy management?
a)
Attending a single one‑hour lecture with no certificate
b)
Not stated in regulations
c)
Completion of an accredited residency
d)
Certification by the Board of Pharmacy Specialties
e)
Completion of a Board‑approved certificate program
50.
Documentation of activities performed under a drug therapy management protocol must be maintained so that it is accessible to:
a)
The general public
b)
Not stated in regulations
c)
Only the patient
d)
Only the pharmacist
e)
Both the authorized prescriber and the pharmacist
51.
According to the drug therapy management guidelines, oral communications between the prescriber and pharmacist must be:
a)
Ignored unless the patient complains
b)
Posted publicly
c)
Summarized in the pharmacist’s documentation and forwarded to the authorized prescriber
d)
Recorded only in the prescriber’s notes
e)
Not stated in regulations
52.
What must a therapy management contract state regarding the patient’s rights?
a)
The patient may terminate the therapy management contract at any time
b)
Termination requires Board approval
c)
The patient may not terminate once treatment begins
d)
Only the pharmacist may terminate the contract
e)
Not stated in regulations
53.
A therapy management contract must include a procedure for periodic review by the authorized prescriber of:
a)
Not stated in regulations
b)
Drugs modified under the prescriber‑pharmacist agreement or changed with the prescriber’s consent
c)
The pharmacist’s salary
d)
The number of prescriptions dispensed per day
e)
The patient’s employment status
54.
Who is responsible for registering technical modifications to a drug therapy management protocol?
a)
Not stated in regulations
b)
The party designated in the prescriber‑pharmacist agreement to receive correspondence from the Boards
c)
The pharmaceutical manufacturer
d)
Only the patient
e)
Any pharmacy technician
55.
Which circumstances require the pharmacist to contact the authorized prescriber under a drug therapy management protocol?
a)
An abnormal laboratory result is detected
b)
The pharmacist modifies a dose or switches an agent
c)
The pharmacist initiates drug therapy under a written protocol
d)
The patient requests contact
e)
The pharmacy floor is busy
56.
Which of the following must a therapy management contract include?
a)
A list of allowable substitutions, if any
b)
Notice to the patient that participation is voluntary
c)
Procedures for periodic review of modified drugs
d)
All of the above
e)
A listing of all generic drugs available statewide
57.
Which of the following topics is not required in a Board‑approved training program for contraceptive prescribing?
a)
Overview of contraceptive medications
b)
Self‑screening risk assessment questionnaire
c)
Standard procedure contraceptive algorithm
d)
None of the above
e)
Detailed cost analysis of all contraceptives
58.
After administering a vaccine, a pharmacist must observe the patient for signs of adverse effects for at least:
a)
15 minutes
b)
30 minutes
c)
One hour
d)
Not stated in regulations
e)
5 minutes
59.
When administering a vaccine outside of a pharmacy, what documentation must the pharmacist maintain for at least 5 years?
a)
Patient’s name, address, and date of birth
b)
Date, route, and site of administration
c)
Vaccine name, dose, lot number, and expiration
d)
Name and address of the patient’s primary care provider
e)
Patient’s employment history
60.
How must vaccination records be maintained under Maryland regulations?
a)
They can be kept off‑site with no retrieval standard
b)
They must be readily retrievable and made available to the Board upon request
c)
They may be destroyed after 1 year
d)
Not stated in regulations
e)
They only need to be maintained for adult patients
61.
What must be disclosed on the consent form used for vaccine administration?
a)
Not stated in regulations
b)
The manufacturer’s quarterly earnings
c)
The patient’s Social Security number
d)
The credentials of the pharmacist administering the vaccination
e)
The name of the patient’s employer
62.
How often must a pharmacist obtain the self‑screening risk assessment questionnaire from a returning patient seeking contraceptive services?
a)
Not stated in regulations
b)
Only once, during the first visit
c)
Whenever the patient changes pharmacies
d)
At least every 12 months
e)
Every 6 months
63.
Under Maryland law, when informing consumers about generic alternatives, the pharmacist must also:
a)
Tell the consumer to ask their physician
b)
Inform the consumer of the approximate cost difference between the generic and the prescribed drug
c)
Provide insurance billing codes
d)
Not stated in regulations
e)
Quote the exact wholesale acquisition cost
64.
What must the Board of Pharmacy maintain regarding interchangeable biological products?
a)
A link on its website to the current FDA lists of interchangeable biological products
b)
An exclusive database of state‑approved brand drugs
c)
A database of patients using interchangeable products
d)
A pricing comparison tool
e)
Not stated in regulations
65.
Which records must a pharmacy maintain when a pharmacist prescribes contraceptives?
a)
Type and dosage of contraceptive or reason for not prescribing
b)
Patient’s identifying information
c)
Copies of visit summaries and risk assessments
d)
All of the above
e)
Copies of the pharmacist’s continuing education certificates
66.
In which situation may a pharmacist bypass the requirement to refer a contraceptive patient to a primary or reproductive health care provider?
a)
When the patient refuses a referral
b)
When the pharmacist is too busy
c)
When the pharmacist knows the patient personally
d)
None of the above
e)
When the pharmacy is located in a grocery store
67.
A generic substitution is NOT permitted when:
a)
The consumer prefers the generic
b)
The substituted drug is therapeutically equivalent
c)
The prescriber does not prohibit substitution
d)
Not stated in regulations
e)
The consumer would be charged more for the substituted drug than for the prescribed product
68.
If a pharmacist fails to inform a consumer about generic drug availability, what recourse does the consumer have?
a)
Not stated in regulations
b)
Sue the prescriber for negligence
c)
Terminate the pharmacist’s employment
d)
The consumer can notify the Board through procedures established for such complaints, and the Board will advise the pharmacist to comply
e)
Change the prescription without notice
69.
Which of the following is NOT required on the vaccination consent form?
a)
Patient signature
b)
A copy provided to the patient
c)
Not stated in regulations
d)
The patient’s employment position
e)
Disclosure of the pharmacist’s credentials
70.
When must the vaccine information statement be provided to the patient?
a)
Not stated in regulations
b)
Only upon patient request
c)
Only after the vaccine is administered
d)
Only if the vaccine is experimental
e)
Before the vaccine is administered
71.
Who must be able to access documentation of activities performed under a vaccination protocol?
a)
Only Board inspectors
b)
Both the authorized prescriber and the pharmacist
c)
Only the pharmacy permit holder
d)
Only the patient
e)
Not stated in regulations
72.
Which vaccinations may a pharmacist administer to an adult without a prescription under a Board‑approved protocol?
a)
Only influenza vaccines
b)
Those listed in the CDC’s recommended immunization schedule or travel guidance
c)
Not stated in regulations
d)
Any vaccine approved by the manufacturer
e)
Vaccines for children only
73.
Which items must the Board develop before pharmacists can prescribe contraceptives?
a)
Self‑screening risk assessment questionnaire
b)
Standard procedure contraceptive algorithm
c)
Notification form
d)
All of the above
e)
Statewide price list of contraceptives
74.
Under Maryland contraceptive prescribing regulations, a pharmacist may prescribe contraceptives before January 1, 2019:
a)
True – the rules were retroactive
b)
Only if supervised by a physician
c)
False – pharmacists were not permitted to prescribe before that date
d)
Only for emergency contraception
e)
Not stated in regulations
75.
What identifying information about the pharmacist must be included in contraceptive prescription records?
a)
The name of the pharmacist who prescribed the contraceptive or decided not to prescribe
b)
Not stated in regulations
c)
Their Social Security number
d)
Their personal home address
e)
Their favorite formulary
76.
Which item does NOT need to be included in a patient’s visit summary after contraceptive prescribing?
a)
Copy of the patient’s completed self‑screening questionnaire
b)
Information about the contraceptive dispensed or reason for not prescribing
c)
Not stated in regulations
d)
Advice to consult a primary care practitioner
e)
A copy of the pharmacist’s professional liability insurance
77.
Under a prescriber‑pharmacist agreement, what must the agreement specify regarding updating patient records?
a)
The methods and time frames within which the pharmacist will update the patient’s record in writing
b)
That records will be updated monthly regardless of activity
c)
That only the prescriber updates records
d)
That updates occur only upon patient request
e)
Not stated in regulations
78.
Which of the following topics is NOT part of the required patient education on preventing medication errors?
a)
Patient rights when receiving medication
b)
Roles in preventing errors
c)
Procedures to report errors
d)
None of the above
e)
The Board’s disciplinary procedures
79.
Which item is NOT required in the Board‑approved vaccination training course?
a)
Not stated in regulations
b)
Responses to vaccination emergencies
c)
Instruction on pharmaceutical marketing strategies
d)
Injection administration techniques
e)
Record keeping and reporting
80.
After prescribing a nicotine replacement therapy medication, which obligations does the pharmacist have?
a)
Counsel the patient on proper use
b)
Provide a visit summary
c)
Record the prescribing and dispensing in any health record
d)
All of the above
e)
Refer the patient to a smoking cessation counselor for all follow-up visits
Reset
